MDGL — MADRIGAL PHARMACEUTICALS INC

Ownership history in STEMPOINT CAPITAL LP  ·  5 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in MADRIGAL PHARMACEUTICALS INC (MDGL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
5.12% (2025 Q2)
Avg. % of fund
2.65%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 17,736 +9,529 +116.1% 1.77% $10.3M $582.34
2025 Q3 REDUCED 8,207 -44,487 -84.4% 0.75% $3.8M $458.66
2025 Q2 ADDED 52,694 +11,758 +28.7% 5.12% $15.9M $302.64
2025 Q1 ADDED 40,936 +20,492 +100.2% 4.32% $13.6M $331.23
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    MDGL price (monthly, adj. close)

Other funds also holding MDGL

As of 2025 Q4 — sorted by position size

PAULSON & CO. INC. 3Y 7Y 30.48% RTW INVESTMENTS, LP 3Y 7Y 11.63% Tao Capital Management LP 3Y 10.53% Avoro Capital Advisors LLC 3Y 7Y 10.35% BAKER BROS. ADVISORS LP 3Y 7Y 7.3% Tri Locum Partners LP 3Y 6.5% MPM BioImpact LLC 3Y 6.45% Nan Fung Group Holdings Ltd 3Y 6.19% Rock Springs Capital Management LP 3Y 7Y 4.17% Resolute Capital Asset Partners LLC 3Y 3.07%
← Back to STEMPOINT CAPITAL LP Holdings